@article{Behrens2020,
  abstract = {Serology testing is explored for epidemiological research and to inform individuals after suspected infection. During the coronavirus disease 2019 (COVID-19) pandemic, frontline healthcare professionals (HCP) may be at particular risk for infection. No longitudinal data on functional seroconversion in HCP in regions with low COVID-19 prevalence and low pre-test probability exist.},
  added-at = {2021-01-28T10:18:58.000+0100},
  author = {Behrens, G M N and Cossmann, A and Stankov, M V and Schulte, B and Streeck, H and Förster, R and Bosnjak, B and Willenzon, S and Boeck, A L and Thu Tran, A and Thiele, T and Graalmann, T and Kayser, M Z and Zychlinsky Scharff, A and Dopfer, C and Horke, A and Pink, I and Witte, T and Wetzke, M and Ernst, D and Jablonka, A and Happle, C},
  biburl = {https://www.bibsonomy.org/bibtex/2b05444fa957793f7cf1ddc0f1bff1880/kalinke},
  day = 01,
  doi = {10.1007/s40121-020-00334-1},
  interhash = {204105043ca9cd7f03e193b52220ca5d},
  intrahash = {b05444fa957793f7cf1ddc0f1bff1880},
  issn = {2193-6382},
  journal = {Infect Dis Ther},
  keywords = {kalinke},
  month = dec,
  number = 4,
  pages = {837-849},
  timestamp = {2021-01-28T10:18:58.000+0100},
  title = {Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals},
  url = {https://pubmed.ncbi.nlm.nih.gov/32886335/},
  volume = 9,
  year = 2020
}